1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer

Medtech innovation briefing [MIB137] Published: 18 January 2018

  • Overview
  • Summary
  • The technologies
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Additional commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

NICE has developed a medtech innovation briefing (MIB) on plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer.

What are MIBs?


  • Next